PMCUF News and Press, Pro Medicus Ltd Ord From 08/09/22

The Project $1M portfolio has had a major leg down in the first half of 2022. Relatively good performances from Visa and Mastercard were unable to offset large declines in Sea Ltd and Meta. While share prices are done, core business performance from many companies that have report...

Pro Medicus Limited (PMCUF) Half Year 2022 Earnings Conference Call February 15, 2022, 07:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Financial Officer Conference Call Participants Bosco Feng - Goldman Sachs Josh Kannourakis -...

After 5 good years, Project $1M had a very tough year in 2021 and had significant underperformance vs. the index. Despite this year's underperformance, the portfolio is still meaningfully up since 2015, the start of the portfolio. Emerging market growth suffered meaningfully, with...

The Project $1M portfolio had a good August, returning 4.7%, beating its target benchmark. A good August hasn't made for a strong year though, and the portfolio trails the S&P500 for 2021, though comfortably outperforms over the last 5 years. A complete exit from China-listed ...

Pro Medicus Limited (PMCUF) Q4 2021 Earnings Conference Call August 17, 2021 9:00 PM ET Company Participants Sam Hupert – Chief Executive Officer Clayton Hatch – Chief Financial Officer Conference Call Participants Peter Meichelboeck – Select Equities David Meehan –...

July was a better month for the Project $1M portfolio, with the portfolio returning 2%, but still finishing down vs. S&P 500. Atlassian spared the portfolio a much worse finish and was the star for the month. Chinese regulatory risk reared its ugly head, significantly impactin...

The Project $1M portfolio has had a challenging time compared to the S&P 500, returning 7% in the first half of the year. In spite of a rough 6 months, the portfolio continues to inch closer to the target 2025 goal of $1M, and is now within 20% of the target. Alphabet, Faceboo...

It was a tough month for the Project $1M portfolio in May, and continues a trend of negative performance against the S&P500 in 2021. The portfolio has been helped by strong performance in Alphabet and Facebook so far this year. Mercadolibre particularly struggled in May and wa...

Project $1M, my long-term growth portfolio designed to deliver $1M in 10 years, had a very tough Q1. The portfolio was caught in the shift in market sentiment from growth to value. Facebook and Alphabet performed relatively well, while ARK Genomic, MercadoLibre, and Teladoc suffer...

Pro Medicus (PMCUF): 1H Net income of A$13.54M.Revenue of A$31.59M (+7.8% Y/Y).Press Release For further details see: Pro Medicus reports 1H results